Search Login Register

Platelet Aggregation Inhibitors (Antiplatelet Drugs) Summary

Description: Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

Also Known As: Antiplatelet Drugs; Blood Platelet Aggregation Inhibitors; Blood Platelet Antagonists; Blood Platelet Antiaggregants; Platelet Inhibitors Show All >>

Networked: 2507 relevant articles (205 outcomes, 286 trials/studies) for this Bio-Agent

Key Diseases for which Platelet Aggregation Inhibitors is Relevant

  1. Stroke (Strokes) : 68 outcomes 77 studies in 525 results
  2. Thrombosis (Thrombus) : 33 outcomes 29 studies in 336 results
  3. Myocardial Infarction : 22 outcomes 24 studies in 190 results
  4. Hemorrhage : 14 outcomes 31 studies in 444 results
  5. Cardiovascular Diseases (Cardiovascular Disease) : 9 outcomes 8 studies in 103 results
Show All >>

Drugs Related to Platelet Aggregation Inhibitors

  1. Aspirin (Acetylsalicylic Acid)
  2. Anticoagulants
  3. clopidogrel (Plavix)
  4. Dipyridamole (Persantine)
  5. Warfarin (Coumadin)
  6. Ticlopidine (Ticlid)
  7. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
  8. Glycoproteins (Glycoprotein)
  9. cilostazol (Pletal)
  10. Heparin (Liquaemin)
Show All >>

Therapies Related to Platelet Aggregation Inhibitors

  1. Stents
  2. Transplants (Transplant)
  3. Carotid Endarterectomy
  4. Angioplasty (Angioplasty, Transluminal)
  5. Plasmapheresis
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.